Status:
ACTIVE_NOT_RECRUITING
Dual Reinforcement Contingency Management for Alcohol Use Disorders
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol Use Disorder
Contingency Management
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Phosphatidylethanol (PEth) is a direct biomarker of alcohol that can detect moderate to heavy drinking with high sensitivity and specificity over 3-week periods. Reinforcing negative PEth results alon...
Eligibility Criteria
Inclusion
- in intensive outpatient treatment
- DSM-5 diagnosis of an alcohol use disorder
Exclusion
- have a condition that may hinder study participation
Key Trial Info
Start Date :
January 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04064463
Start Date
January 22 2020
End Date
September 1 2025
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Village
Hartford, Connecticut, United States, 06105